1 |
Archer JS, Chang JL.Hirsutism and acne in polycystic ovary syndrome [J].Best Pract Res Clin Obstet Gynaecol, 2004,18(9):737-754.
|
2 |
Wang YH, Chen L, Chen H, et al. Gestational insulin resistance and lipid metabolism in pregnant women with polycystic ovary syndrome [J/CD].Chin J Obstet Gynecol Pediatr:Electron Ed, 2010,6(4):239-245.
|
3 |
Li Y, Fan P, Bai H, et al. PAF-AH activity in patients with PCOS andits correlation with glucose and lipid metabolism research[J]. J Sichuan Univ: Med Ed, 2009,40(6):1066-1070.
|
4 |
Wan DH, Fan P, Bai H, et al. Polycystic ovary syndrome patients with platelet-activating factor acetyl hydrolase activity and insulin resistance[J]. Chin J Obstet Gynecol, 2010,45(1):30-34.
|
5 |
Dokras A.Cardiovascular disease risk factors in polycystic ovary syndrome[J].Semin Reprod Med,2008,26(1):39-44.
|
6 |
Shaw LJ, Bairey-Merz CN, Azziz R, et al.Postmenopausal women with a history of inegular menses an elevated androgen measurement at high risk for worsening cardiovascular event-free survival: Results from the National Institutes of Health-National Heart,Lung,and Blood Institute sponsored women's ischemia syndrome Evaluation[J].J Clin Endocrinol Metab,2008,93(4):1276-1284.
|
7 |
Shoff R, Kerchner A, Maifeld M, et al.Young obese women with polysystic ovary syndrome have evidence of early coronary atherosclerosis[J]. J Clin Endocrinol Metab,2007,92(12):4609-4614.
|
8 |
Xu LZ, Shan D. Polycystic ovary syndrome: A metabolic disorder of systemic disease expression in ovarian [J/CD].Chin J Obstet Gynecol Pediatr:Electron Ed, 2011, 7(4):407-411.
|
9 |
Ovalle F, Azziz R.Insulin resistance,polyeystie ovary syndrome,and type 2 diabete mellitus [J].Fertil Steril,2002,77(6):1095.
|
10 |
Legro RS. Polycystie ovary syndrome and cardiovascular disease:A prematrue association[J]. J Endocr Rev,2003,24(3):302-312.
|
11 |
Chen ZJ, Shi YH, Zhao YR, et al.Insulin receptor gene polymorphism in the pathogenesis of polycystic ovary syndrome[J]. Chin J Obstet Gynecol,2004,39:582-585.
|
12 |
Jin L, Zhu XM, Luo Q, et al. A novel SNP at exon 17 of INSR is associated with decreased insulin sensitivity in Chinese women with PCOS[J].Mol Hum Reprod,2006,12:151-155.
|
13 |
Korhonen S, Romppanen EL, Hihunen M, et al.Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are associated with polycystic ovary syndrome[J].Fertil Steril,2003,79:1353-1357.
|
14 |
San Millan JL, Corton M, Villuendas G, et al.Association of the polycystic ovary syndrome with genomic variants related to insulin resistancc,type 2 diabetes mellitus, and obesity[J]. J Clin Endocrinol Metab,2004,89:2640-2646.
|
15 |
Camps J, Marsillach J, Joven J. The paraoxonases:Role in human diseases and methodological difficulties in measurement[J]. Crit Rev Clin Lab Sci, 2009, 46(2):83-106.
|
16 |
Zhang F, Fan P, Bai H, et al. Polycystic ovary syndrome paraoxonase 1 gene -108 C / T polymorphism[J].J Sichuan Univ:Med Ed, 2011,1(6):24-28.
|
17 |
Xita N, Ge Orgiou I, Chatzikyriakidou A, et al.Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome[J].Clin Chem,2005,51:416-423.
|
18 |
Xita N, Georgiou I, Tsatsoulis A, et al.A polymorphism in the resistin promoter is associated with body mass index in women with polycystic ovary syndrome[J].Fertil Steril,2004,82:1466-1467.
|
19 |
Shi YH, Sheng Y, Chen ZJ, et al.Resistin gene intron 2 polymorphism with polycystic ovary syndrome research[J]. J Shandong Univ:Med Ed,2005, 43:694-696.
|
20 |
Gonzalez A, Abril E, Roca A, et al.Specific CAPN10 gene haplotypes influence the clinical profile of polycystic ovary patients[J].Clin Endocrinol Metab,2003,88:5529-5536.
|
21 |
Guan LX, Ji XW, Wang JX.et al. Plasminogen activator inhibitor-1 gene promoter polymorphism and the Chinese people care about -6754G/5G disease-related research[J]. Chin J Gene,2002,19:393-396.
|
22 |
Chu XM, He BX. Plasminogen activator inhibitor-1 gene polymorphisms and metabolic syndrome[J]. J Cardiol,2004,2:184-186.
|
23 |
Li N, Cong J, Wu XK, et al.Polycystic ovary syndrome susceptibility gene research[J].J Med Res,2010,1:122-124.
|
24 |
Korhonen S, Heinonen S, Hihunen M, et al.Polymorphism in the peroxisome proliferator-activated receptor gamma gene in women with polycystic ovary syndrome[J].Hum Reprod,2003,18:540-543.
|
25 |
Peral B, San Millan JL, Castello R, et al. Comment: The methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1 B)is associated with the polycystic ovary syndrome and hyperandrogenism[J].J Clin Endocrinol Metab, 2002,87:3977-3983.
|
26 |
Kaibe M, Takakuwa K, Murakawa H, et al. Studies on the human leukocyte antigens in patients with polycystic ovary syndrome in a Japanese population:Possible susceptibility of HIA-A11 and DRB1*0403 to patient population with polycystic ovary syndrome[J].Am J Reprod Immunol,2006,55:301-306.
|
27 |
Glueck CJ, Sieve L, Zhu B, et al. Plasminogen activator inhibitor activity,4G 5G polymorphism of the plasminogen activator inhibitor l gene, an d first trimester miscarriage in women with polycystic ovary syndrome[J].Metabolism,2006,55:345-352.
|
28 |
Orion F Jr, Palomba S, Cascella T, et al. Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrom[J]? Reprod Biomed Online,2004,9:505-510.
|
29 |
Zhao JL, Chen ZJ, Zhao YR, et al.Plasminogen activator inhibitor-l gene promoter 4G and 5G polymorphism genotype distribution and correlation study of polycystic ovary syndrome[J].Chin J Obstet Gynecol,2005,40:528-531.
|
30 |
Kolbus A, Walch K, Nagele F, et al.Huber Interleu-kin-1 alpha but not interleukin-1beta gene polymorphism is associated with polycystic ovary syndrome [J].J Reprod Immunol,2006,10(4):1-6.
|